Pfizer

August 22, 2007 Pfizer groundbreaking in Chesterfield.
File Photo | Bill Greenblatt

St. Louis County is getting another big business development.

Pfizer is partnering with Clayco and CRG for a new $200 million facility in Chesterfield. Clayco and its real estate subsidiary CRG will construct and own the building, while Pfizer will have a long-term lease.

The biopharmaceutical company has 450 employees at two facilities in the St. Louis region, and plans to create 80 new positions for the new facility.

U.S. National Library of Medicine, National Institutes of Health

Missouri will receive $693,000 as part of a nationwide settlement over the kidney transplant drug, Rapamune.

Neighboring Illinois will get more than $1.3 million.

The drug company Pfizer, whose subsidiary Wyeth makes Rapamune, has agreed to pay out a total of $35 million to 41 U.S. states and the District of Columbia as part of the settlement.

Pfizer.com

Pfizer employs about 500 people in research facilities around St. Louis, according to the St. Louis Business Journal. A shift at the very top of the corporation comes at a trying time for the drugmaking giant.